The Editors of Journal of Neurology and Experimental Neuroscience (JNEN) would like to express their tremendous gratitude to all those individuals who participated in the peer review process during the preparation of this Volume – 10 (2024).
Read MoreSumith Reddy Atla, P Sonalika Reddy, Thatikonda Ganesh and Poorvi M Patill
The gut microbiota plays a crucial role in brain development and function, influencing various neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disabilities (ID). Dysbiosis, or an imbalance in the gut microbiota, has been linked to altered neuroinflammation, impaired blood-brain barrier (BBB) integrity, and changes in neurotransmitter production, all of which contribute to NDD pathophysiology.
Lin Zhang
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. Characterized by cognitive decline, behavioral changes, and impaired daily functioning, AD’s complex pathology-including amyloid-beta (Aβ) plaques and tau neurofibrillary tangles-has hindered accurate diagnosis and effective treatment. This mini review discusses current diagnostic advancements and therapeutic interventions aimed at addressing these challenges.
Ezekiel Suhas Yagnamurthy, Forum Hetalkumar Joshi, Kambalapally Rohit and Marri Manichandan
There are many names for primary central nervous system lymphoma (PCNSL), such as reticulum cell sarcoma, diffuse histiocytic lymphoma, and microglioma. Initially, there was uncertainty about the origin of the cell, which is reflected in the proliferation of names. PCNSL is an extranodal, high-grade non-Hodgkin B-cell neoplasm that usually consists of large cells or immunoblasts. Brain tissue, cerebrospinal fluid, the spinal cord, or the eyes can produce it.